1. World Health Organization
11 November 2018
Progress Towards Global Immunization Goals
Summary presentation of key indicators
Updated July 2018

2. World Health Organization
Global and Regional Immunization overage with three doses of diphtheria, tetanus, and pertussis (DTP3) containing vaccines, ,
global coverage at 85% in 2017
11 November 2018
Source: WHO/UNICEF coverage estimates 2017 revision, July 2018.
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 15 July 2018.

3. Immunization coverage with DTP3 containing vaccines in infants (from <50%), 2017
<50% (8 countries or 4%)
50-79% (21 countries or 11%)
80-89% (42 countries or 22%)
>=90% (123 countries or 63%)
Not available
Source: WHO/UNICEF coverage estimates 2017 revision, July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018.
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

4. Countries sustaining >90% DTP3 coverage, 2015-2017
<90% (81 countries or 42%)
>=90% (113 countries or 58%)
Not available
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved
Source: WHO/UNICEF coverage estimates 2017 revision, July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018.

5. World Health Organization
Coverage with DTP3 containing vaccines, by country income levels,
World Health Organization
11 November 2018
95%
High-income countries
85%
78%
Global
Low-income countries
Source: WHO/UNICEF coverage estimates 2017 revision, July 2018, and Country Income Categories (World Bank), as of June 2018.
Income classification not available for: Cook Islands and Niue
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 16 July 2018.

6. Number of countries reached and sustained 90% coverage with 3 doses of DTP containing vaccines since 2000, and global DTP3 coverage
Source: WHO/UNICEF coverage estimates 2017 revision,. July United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 15 July 2018.

7. World Health Organization
19.9 million infants not immunized (DTP3), 2017
11 November 2018
Source: WHO/UNICEF coverage estimates 2017 revision, July United Nations, Population Division. The World Population Prospects revision. New York, 2017.
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 15 July 2018.

8. Top 10 countries with most under- and un-vaccinated children (DTP3), in 2017
Source: WHO/UNICEF coverage estimates 2017 revision, July 2018.
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 18 July 2018.

9. GLOBAL Annual surviving infants cohort = 136.1 million
World Health Organization
GLOBAL Annual surviving infants cohort = million
11 November 2018
85% DTP3 coverage million children vaccinated
Source: WHO/UNICEF coverage estimates 2017 revision, July United Nations, Population Division. The World Population Prospects revision. New York, 2017.
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 15 July 2018.

10. “Developing”* countries with all districts achieving at least 80% DTP3 coverage, 2017
All districts >= 80% (39 countries or 25%)
*155 developing countries and economies in transition per UN World Economic & Social Survey, 2018 classification
Not all districts >=80% (104 countries or 67%)
No district data available (12 countries or 8%)
Developed economies (39 countries)
Not available
Source1: WHO/IVB Database, as at 27 June Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization.
194 WHO Member States. Date of slide: 25 July 2018.
Not applicable
1. District data not reported in the annual data collection Joint Reporting Form district table of sheet 6 was supplemented from the annual subnational coverage data collection mechanism.
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

11. “Developing”* countries with % of districts achieving at least 80% DTP3 coverage, 2017
<50% of districts (30 countries or 19%)
*155 developing countries and economies in transition per UN World Economic & Social Survey, 2018 classification
50-79% of districts (31 countries or 20%)
80-99% of districts (43 countries or 28%)
100% of districts (39 countries or 25%)
Developed economies (39 countries)
Source1: WHO/IVB Database, as at 27 June Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization.
194 WHO Member States. Date of slide: 25 July 2018.
Not Available (12 countries or 8%)
Not applicable
1. District data not reported in the annual data collection Joint Reporting Form district table of sheet 6 was supplemented from the annual subnational coverage data collection mechanism.
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

12. World Health Organization
11 November, 2018
Member States by the percent of districts with DTP3 coverage of ≥ 80% for 2017
Not available (34 Member States or 18% with 6 MS having administrative coverage DTP3 data not valid)
Not applicable
WHO-UNICEF (WUENIC) estimate is < 90% or differs from country administrative coverage reported on the JFR and therefore district data are not considered valid (46 Member States or 24%)
50-79% (32 Member States or 16%, 13 of which administrative coverage DTP3 data considered not valid)
< 50% (31 Member States or 16%, 16 of which administrative coverage DTP3 data considered not valid)
80-99% (47 Member States or 24%, 11 of which administrative coverage DTP3 data considered not valid)
All districts (50 Member States or 26%, 0 of which administrative coverage DTP3 data considered not valid)
Source1: WHO/IVB Database, as at 27 June 2018 and WHO/UNICEF coverage estimates 2017 revision, July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 25 July 2018.
1. District data not reported in the annual data collection Joint Reporting Form district table of sheet 6 was supplemented from the annual subnational coverage data collection mechanism.
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

13. Immunization coverage with 1st dose of measles containing vaccines (MCV1) in infants, 2017
<50% (8 countries or 4%)
50-79% (27 countries or 14%)
80-89% (41 countries or 21%)
>=90% (118 countries or 61%)
Not available
Source: WHO/UNICEF coverage estimates 2017 revision, July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018.
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

14. World Health Organization
ARE WE ON TRACK TO REACH OUR GVAP COVERAGE GOALS?
Global Immunization and
projections to reach 90% global coverage goals in MCV1 coverage
11 November 2018
Source: WHO/UNICEF coverage estimates 2017 revision, July 2018
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 15 July 2018.

15. World Health Organization
Immunization coverage with Rubella containing vaccines 1st dose* (RCV1) in infants, 2017
11 November, 2018
Coverage estimates are based on WHO and UNICEF estimates of coverage for the dose of measles containing vaccine that corresponds to the first measles-rubella combination vaccine
<50% (2 countries or 1%)
*coverage estimates for the 1st dose of rubella containing vaccine are based on WHO and UNICEF estimates of coverage of measles containing vaccine.
50-79% (13 countries or 7%)
80-89% (34 countries or 18%)
90-94% (36 countries or 19%)
>95% (77 countries or 40%)
Source: WHO/UNICEF coverage estimates 2017 revision, July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 17 July 2018.
Not available or Rubella vaccine not introduced (32 countries or 16%)
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

16. World Health Organization
Number of countries having introduced Hepatitis B vaccine and global infant coverage for Hepatitis B 3rd dose (HepB3),
11 November 2018
Source: WHO/UNICEF coverage estimates 2017 revision, July 2018, and WHO database as at 06 July Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018.
2017: excluding 3 countries where HepB administered for adolescents

17. Immunization coverage with HepB3 in infants, 2017
<50% (7 countries or 4%)
50-79% (24 countries or 13%)
80-89% (40 countries or 22%)
>=90% (114 countries or 62%)
Source: WHO/UNICEF coverage estimates 2017 revision, July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018.
Not available / HepB not introduced or no coverage data available (9 countries or 5%)
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

18. Pneumococcal and Rotavirus vaccine coverage by income status, 2006-2017
Pneumococcal vaccine
introduced in 139* member states
Rotavirus vaccine
introduced in 96** member states
Source: WHO/UNICEF coverage estimates 2017 revision, July 2018.
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of slide: 15 July 2018.
*partial introduction for 5 countries
**partial introduction for 6 countries

19. Immunization coverage with Pneumococcal Conjugate Vaccine 3rd dose (PCV3) in infants, 2017
<50% (6 countries or 3%)
50-79% (25 countries or 13%)
80-89% (36 countries or 19%)
>=90% (67 countries or 35%)
PCV in schedule but no coverage data available (5 countries1 or 3%)
Source: WHO/UNICEF coverage estimates 2017 revision, July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018.
Not available / not in national immunization schedule1 (55 countries1 or 28%)
Not applicable
1. Poland reported PCV3 introduction in the 2017 national immunization schedule but data was received on 06 July 2018 and therefore did not meet the WHO/UNICEF coverage estimate deadline.
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

20. Immunization coverage with Rotavirus vaccine in infants, 2017
<50% (9 countries or 5%)
50-79% (21 countries or 11%)
80-89% (23 countries or 12%)
>=90% (37 countries or 19%)
Rotavirus vaccine in schedule but no coverage data available (6 countries1 or 3%)
Source: WHO/UNICEF coverage estimates 2017 revision, July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018.
Not available / not in national immunization schedule (98 countries1 or 51%)
Not applicable
1. Thailand reported partial introduction for a pilot project in two provinces. WHO does not accept pilot projects as included in the national immunization schedule and therefore no coverage estimates were completed.
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

21. World Health Organization
11 November 2018
Global coverage estimates, BCG, DTP1, DTP3, Polio3, MCV1, HepB3 and Hib3
Source: WHO/UNICEF coverage estimates 2017 revision, July 2018.
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of Slide: 15 July 2018.

22. World Health Organization
Global coverage estimates, BCG, DTP 1st and 3rd, Measles 1st and 2nd, Rubella 1st, HepB birth and 3rd, Hib3, Pol3, YFV, PCV3 and Rota (last dose)
11 November 2018
Source: WHO/UNICEF coverage estimates 2017 revision, July 2018.
Immunization Vaccines and Biologicals, (IVB), World Health Organization.
194 WHO Member States. Date of Slide: 15 July 2018.

23. World Health Organization
Number of vaccines/antigens introduced in national immunization schedules compared to 2017
World Health Organization
11 November 2018
Selected antigens are :
Diphtheria, Tetanus, Pertussis, Measles, Polio - universal use
Hepatitis B,
Heamophilius Influenza type B,
Pneumococcal conjugate
Rotavirus
Rubella
2000
5 antigens (DTP, Measles and Polio)
6 antigens
7 antigens
8 antigens
9 antigens
≥10 antigens
Not applicable
Source: WHO/IVB Database, as at 27 June Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization.
194 WHO Member States. Date of slide: 23 July 2018.
2017
Not available
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

24. World Health Organization
Countries having introduced Hib vaccine
in 1997 and 2017
11 November 2018
1997
29 countries introduced
2 countries partially introduced
2017
190 countries introduced
1 countries partially introduced
Source: WHO/UNICEF coverage estimates 2017 revision, July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018.
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

25. Polio Eradication Progress, 1988 – 2017
World Health Organization
Polio Eradication Progress, 1988 – 2017
11 November 2018
Certified polio-free regions (126 countries)
Endemic with wild poliovirus (3 countries)
Not certified but non-endemic (65 countries)
Source: WHO/POLIO database, as of July 2018.
194 WHO Member States.
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

26. World Health Organization
Progress in Polio Eradication,
Estimated and Reported Polio Cases,
11 November 2018
1988: WHA Resolution to Eradicate Polio
2000: Original Target Date for Interruption of Transmission Reported cases:
Estimated cases: 3 500
1999: WHA Resolution to accelerate polio eradication activities
2017: Reported wild poliovirus cases: 22
Source: WHO/POLIO database, as of July 2018.
194 WHO Member States.

27. 44 Countries eliminated MNT between 2000 & December 2017
44 Countries eliminated MNT between 2000 & December 2017 *(Plus Ethiopia except Somali region and the South Eastern zone of Nigeria) leaving 15 countries yet to eliminate MNT

28. Countries providing vitamin A supplementation with routine and/or supplementary immunization activities, 2017
Vitamin A distributed with routine and supplementary immunization activities (14 countries or 7%)
Vitamin A distributed only with routine immunization services (55 countries or 28%)
Vitamin A distributed only with supplementary immunization activities (6 countries or 3%)
Source: WHO/UNICEF database as at 06 July 2018.
Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 11 July 2018.
Not available/No Vitamin A distribution (119 countries or %)
Not a Countdown country (119) or Countdown country for which Vitamin A deficiency is not a public health problem (2)
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

29. World Health Organization
Countries with a 3-5 year strategic plan for the national immunization system, 2017
11 November 2018
Yes (149 countries or 77%)
No (36 countries or 19%)
No data (9 countries or 5%)
Not available
Source: WHO/IVB Database, as at 06 July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization.
194 WHO Member States. Date of slide: 15 July 2018.
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

30. World Health Organization
Countries with a national annual work plan for immunization services, 2017
11 November 2018
Yes (171 countries or 88%)
No (12 countries or 6%)
No data (11 countries or 6%)
Not available
Source: WHO/IVB Database, as at 06 July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization.
194 WHO Member States. Date of slide: 15 July 2018.
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

31. World Health Organization
Countries having a policy being implemented for immunization injection safety, 2017
11 November 2018
Yes (152 countries or 78%)
No (20 countries or 10%)
No data (22 countries or 11%)
Not available
Source: WHO/IVB Database, as at 06 July Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization.
194 WHO Member States. Date of slide: 15 July 2018.
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.

32. National Immunization Technical Advisory Groups (NITAGs) in 2017
99 Countries meeting the 6 NITAG criteria
131 Countries having a NITAG with administrative or legislative basis
131 Countries Reporting the Existence of A NITAG with Terms of Reference
133 Countries Reporting the Existence of a NITAG
Source: WHO/IVB Database, as at 28 June Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization.
194 WHO Member States. Date of slide: 15 July 2018.
Not available
Not applicable
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved.